相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Long-Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents
Fasiha Kanwal et al.
HEPATOLOGY (2020)
Tenofovir Is Associated With Lower Risk of Hepatocellular Carcinoma Than Entecavir in Patients With Chronic HBV Infection in China
Terry Cheuk-Fung Yip et al.
GASTROENTEROLOGY (2020)
Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antivirals
Monica Pons et al.
JOURNAL OF HEPATOLOGY (2020)
Reassessing the accuracy of PAGE-B-related scores to predict hepatocellular carcinoma development in patients with chronic hepatitis B
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2020)
Risk Scores for Hepatocellular Carcinoma in Chronic Hepatitis B: A Promise for Precision Medicine
George V. Papatheodoridis et al.
HEPATOLOGY (2020)
Hepatic Fat-Genetic Risk Score Predicts Hepatocellular Carcinoma in Patients With Cirrhotic HCV Treated With DAAs
Elisabetta Degasperi et al.
HEPATOLOGY (2020)
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan et al.
JOURNAL OF HEPATOLOGY (2020)
Personalized surveillance for hepatocellular carcinoma in cirrhosis - using machine learning adapted to HCV status
Etienne Audureau et al.
JOURNAL OF HEPATOLOGY (2020)
A Model Based on Noninvasive Markers Predicts Very Low Hepatocellular Carcinoma Risk After Viral Response in Hepatitis C Virus-Advanced Fibrosis
Sonia Alonso Lopez et al.
HEPATOLOGY (2020)
Detectable HBV DNA during nucleos(t)ide analogues stratifies predictive hepatocellular carcinoma risk score
Shun Kaneko et al.
SCIENTIFIC REPORTS (2020)
Hepatocellular carcinoma incidence with tenofovir versus entecavir in chronic hepatitis B: a systematic review and meta-analysis
Cheng-Hao Tseng et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)
Assessment of a Deep Learning Model to Predict Hepatocellular Carcinoma in Patients With Hepatitis C Cirrhosis
George N. Ioannou et al.
JAMA NETWORK OPEN (2020)
Reduced Incidence of Hepatocellular Carcinoma in Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis B Treated With Tenofovir-A Propensity Score-Matched Study
Mindie H. Nguyen et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 29, pg iv238, 2018)
A. Vogel et al.
ANNALS OF ONCOLOGY (2019)
Prediction model for hepatocellular carcinoma risk in treatment-naive chronic hepatitis B patients receiving entecavir/tenofovir
Jung Hwan Yu et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2019)
HCV-Induced Epigenetic Changes Associated With Liver Cancer Risk Persist After Sustained Virologic Response
Nourdine Hamdane et al.
GASTROENTEROLOGY (2019)
Hepatocellular carcinoma in the setting of alcohol-related liver disease
Nathalie Ganne-Carrie et al.
JOURNAL OF HEPATOLOGY (2019)
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort study
Fabrice Carrat et al.
LANCET (2019)
Combined Analysis of Metabolomes, Proteomes, and Transcriptomes of Hepatitis C Virus-Infected Cells and Liver to Identify Pathways Associated With Disease Development
Joachim Lupberger et al.
GASTROENTEROLOGY (2019)
Models estimating risk of hepatocellular carcinoma in patients with alcohol or NAFLD-related cirrhosis for risk stratification
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2019)
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B A Korean Nationwide Cohort Study
Jonggi Choi et al.
JAMA ONCOLOGY (2019)
Cost Effectiveness of Hepatocellular Carcinoma Surveillance After a Sustained Virologic Response to Therapy in Patients With Hepatitis C Virus Infection and Advanced Fibrosis
Hooman Farhang Zangneh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Magnetic Resonance Imaging Is Cost-Effective for Hepatocellular Carcinoma Surveillance in High-Risk Patients With Cirrhosis
Hye-Lin Kim et al.
HEPATOLOGY (2019)
Management of patients with pre-therapeutic advanced liver fibrosis following HCV eradication
Pierre Nahon et al.
JHEP REPORTS (2019)
AASLD guidelines for the treatment of hepatocellular carcinoma
Julie K. Heimbach et al.
HEPATOLOGY (2018)
Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study
Charlotte E. Costentin et al.
GASTROENTEROLOGY (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma After Direct Antiviral Therapy for HCV in Patients With Cirrhosis Included in Surveillance Programs
Pierre Nahon et al.
GASTROENTEROLOGY (2018)
Incidence of Hepatocellular Carcinoma in Patients With HCV-Associated Cirrhosis Treated With Direct-Acting Antiviral Agents
Vincenza Calvaruso et al.
GASTROENTEROLOGY (2018)
The risk of hepatocellular carcinoma in cirrhotic patients with hepatitis C and sustained viral response: Role of the treatment regimen
Hamish Innes et al.
JOURNAL OF HEPATOLOGY (2018)
Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine
Naoto Fujiwara et al.
JOURNAL OF HEPATOLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Recommendations on Treatment of Hepatitis C 2018
JOURNAL OF HEPATOLOGY (2018)
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF HEPATOLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Development of models estimating the risk of hepatocellular carcinoma after antiviral treatment for hepatitis C
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Modified PAGE-B score predicts the risk of hepatocellular carcinoma in Asians with chronic hepatitis B on antiviral therapy
Ji Hyun Kim et al.
JOURNAL OF HEPATOLOGY (2018)
GLOBOCAN 2018: counting the toll of cancer
[Anonymous]
LANCET (2018)
Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection
Kentaro Matsuura et al.
GASTROENTEROLOGY (2017)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Risk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Fasiha Kanwal et al.
GASTROENTEROLOGY (2017)
The Risk of Hepatocellular Carcinoma Decreases After the First 5 Years of Entecavir or Tenofovir in Caucasians With Chronic Hepatitis B
George V. Papatheodoridis et al.
HEPATOLOGY (2017)
Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication
Adriaan J. van der Meer et al.
JOURNAL OF HEPATOLOGY (2017)
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
JOURNAL OF HEPATOLOGY (2017)
HCC Risk Scores: Useful or Not?
Morris Sherman
SEMINARS IN LIVER DISEASE (2017)
Prediction model of hepatocellular carcinoma risk in Asian patients with chronic hepatitis B treated with entecavir
Chien-Hung Chen et al.
ONCOTARGET (2017)
Cost-Effectiveness of Risk Score-Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
Nicolas Goossens et al.
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY (2017)
MRI With Liver-Specific Contrast for Surveillance of Patients With Cirrhosis at High Risk of Hepatocellular Carcinoma
So Yeon Kim et al.
JAMA ONCOLOGY (2017)
Risk score model for the development of hepatocellular carcinoma in treatment-naive patients receiving oral antiviral treatment for chronic hepatitis B
Won Sohn et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients
Sarah Berhane et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Risk of Hepatocellular Carcinoma After Sustained Virological Response in Veterans With Hepatitis C Virus Infection
Hashem B. El-Serag et al.
HEPATOLOGY (2016)
Nomogram for Individualized Prediction of Hepatocellular Carcinoma Occurrence in Hepatitis C Virus Cirrhosis (ANRS CO12 CirVir)
Nathalie Ganne-Carrie et al.
HEPATOLOGY (2016)
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2016)
Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients
Tung-Hung Su et al.
LIVER INTERNATIONAL (2016)
Why cancer screening has never been shown to save lives-and what we can do about it
Vinay Prasad et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Why cancer screening has never been shown to save lives-and what we can do about it
Vinay Prasad et al.
BMJ-BRITISH MEDICAL JOURNAL (2016)
Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
Jean-Claude Trinchet et al.
HEPATOLOGY (2015)
Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Risk of hepatocellular carcinoma in chronic hepatitis B: Assessment and modification with current antiviral therapy
George V. Papatheodoridis et al.
JOURNAL OF HEPATOLOGY (2015)
Prediction of Development of Liver-Related Events by Transient Elastography in Hepatitis B Patients With Complete Virological Response on Antiviral Therapy
Hye Won Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)
Factors That Affect Efficacy of Ultrasound Surveillance for Early Stage Hepatocellular Carcinoma in Patients With Cirrhosis
Paolo Del Poggio et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Mortality, Liver Transplantation, and Hepatocellular Carcinoma Among Patients With Chronic Hepatitis B Treated With Entecavir vs Lamivudine
Young-Suk Lim et al.
GASTROENTEROLOGY (2014)
Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B-A Nationwide Cohort Study
Chun-Ying Wu et al.
GASTROENTEROLOGY (2014)
A New Laboratory-Based Algorithm to Predict Development of Hepatocellular Carcinoma in Patients With Hepatitis C and Cirrhosis
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2014)
Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease
Ju-Yeon Cho et al.
GUT (2014)
Hepatocarcinogenesis in chronic hepatitis C patients achieving a sustained virological response to interferon: significance of lifelong periodic cancer screening for improving outcomes
Naoki Yamashita et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Machine Learning Algorithms Outperform Conventional Regression Models in Predicting Development of Hepatocellular Carcinoma
Amit G. Singal et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma A Meta-analysis of Observational Studies
Rebecca L. Morgan et al.
ANNALS OF INTERNAL MEDICINE (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Long-Term Entecavir Treatment Reduces Hepatocellular Carcinoma Incidence in Patients With Hepatitis B Virus Infection
Tetsuya Hosaka et al.
HEPATOLOGY (2013)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis
Adriaan J. van der Meer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis
Pierre Nahon et al.
JOURNAL OF HEPATOLOGY (2012)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
Predicting cirrhosis risk based on the level of circulating hepatitis B viral load
UH Iloeje et al.
GASTROENTEROLOGY (2006)
Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level
CJ Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Lamivudine for patients with chronic hepatitis B and advanced liver disease
YF Liaw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
分享论文
